Long-Term Efficacy of Adjunctive Pharmaceutical Protocols for Seizure Reduction in the Japan Dravet Syndrome Sector of 2025
The management of drug-resistant seizures in late 2025 relies on a multi-modal pharmacological approach that integrates traditional anti-epileptic agents with newer, targeted molecules. In Japan, long-term post-marketing studies have demonstrated that stiripentol, when used as an add-on therapy with clobazam and valproate, significantly reduces the frequency of convulsive and myoclonic seizures...
0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior